Clinical and translational attributes of immune-related adverse events
KPM Suijkerbuijk, MJM van Eijs, F van Wijk… - Nature Cancer, 2024 - nature.com
With immune checkpoint inhibitors (ICIs) becoming the mainstay of treatment for many
cancers, managing their immune-related adverse events (irAEs) has become an important …
cancers, managing their immune-related adverse events (irAEs) has become an important …